Defibrillators Market to Reach US$ 22.29 Billion by 2031 | North America Leads with 38% Share | Top Companies - Medtronic, Abbott, Philips, Boston Scientific

Leander, Texas and Tokyo, Japan - Feb.3.2026
As per DataM Intelligence research report "Defibrillators Market reached US$ 12.88 billion in 2023 and is expected to reach US$ 22.29 billion by 2031 growing with a CAGR of 7.1%% from 2024 to 2031."

The market is driven by rising incidence of cardiovascular diseases, sudden cardiac arrest (SCA) cases, aging population, growing public access defibrillation programs, and increasing installations in hospitals, ambulances, airports, schools, sports arenas, and corporate offices. Technological advancements in automated external defibrillators (AEDs), implantable cardioverter defibrillators (ICDs), wearable defibrillators, and improvements in battery life, ease-of-use, connectivity, and biphasic waveform technology support widespread adoption. Despite high device cost and need for regular maintenance & training, demand remains strong due to regulatory mandates, growing awareness of SCA survival rates, and expansion of public-access AED programs.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/defibrillators-market?sindhuri
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Defibrillators Market: Competitive Intelligence
Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., ZOLL Medical Corporation (Asahi Kasei), Stryker Corporation, Nihon Kohden Corporation, Schiller AG, CU Medical Systems, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

The Defibrillators Market continues to gain structural strength through the combined influence of Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., ZOLL Medical Corporation, Stryker Corporation, Nihon Kohden Corporation, Schiller AG, CU Medical Systems, and Mindray. Together, these companies support critical end-use settings including hospitals & clinics, public access locations, emergency medical services (EMS), home care, and ambulatory surgical centers, where rapid response, high success rate in restoring normal heart rhythm, reliability under stress, and user-friendly interface remain essential. Their portfolios help address demanding requirements including real-time CPR feedback, connectivity for remote monitoring, pediatric capability, and long battery life. As a result, the Defibrillators Market benefits from steady demand, continuous technological refinement, and broad clinical & public relevance despite ongoing focus on cost-containment and training compliance.

The collective momentum created by these companies enhances the competitive depth of the Defibrillators Market by combining global scale with specialized expertise. Medtronic, Abbott, Boston Scientific, and Philips bring extensive R&D capabilities, strong clinical evidence portfolios, regulatory leadership, and multinational distribution networks that reinforce market leadership and physician/customer trust. At the same time, ZOLL, Stryker, Nihon Kohden, Schiller, CU Medical, and Mindray contribute application-specific innovation, particularly in public-access AEDs, EMS-grade devices, cost-effective hospital solutions, and emerging wearable technologies. This balance of scale, specialization, and geographic reach supports consistent product availability and enables faster adaptation to evolving clinical guidelines, connectivity standards, and public-access requirements.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/defibrillators-market?sindhuri
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Fund Raisings
✅ January 2026 - ZOLL Medical Corporation (United States)
ZOLL secured strategic investment to expand manufacturing capacity for next-generation AEDs and wearable defibrillators. The funding supports enhanced connectivity features and public-access program scale-up.
✅ December 2025 - CU Medical Systems, Inc. (South Korea)
CU Medical directed growth capital toward R&D and global expansion of cost-effective AEDs targeted at emerging markets and public venues.
✅ November 2025 - Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
Mindray invested in advanced defibrillator production lines and digital health integration to strengthen its hospital and EMS-grade portfolio.

Product Launches & Partnerships
✅ January 2026 - Koninklijke Philips N.V. (Netherlands)
Philips launched its latest HeartStart AED series with improved real-time CPR coaching, faster shock delivery, and cloud-connected data transmission for better post-event analysis.
✅ December 2025 - ZOLL Medical Corporation (United States)
ZOLL introduced an upgraded public-access AED platform featuring longer battery life, pediatric attenuation, and integration with emergency dispatch systems.
✅ October 2025 - Stryker Corporation (United States)
Stryker released a new line of EMS-grade defibrillators/monitors with enhanced waveform technology, modular design, and advanced connectivity for hospital-to-ambulance data continuity.

Mergers & Acquisitions
✅ January 2026 - Abbott Laboratories (United States)
Abbott expanded its cardiovascular rhythm management portfolio through strategic acquisition of a next-generation wearable defibrillator technology company.
✅ November 2025 - Nihon Kohden Corporation (Japan)
Nihon Kohden acquired a regional AED distributor and service provider to strengthen its public-access and hospital channel presence in key Asia-Pacific markets.
✅ October 2025 - Boston Scientific Corporation (United States)
Boston Scientific completed acquisition of a company specializing in advanced ICD leads and remote monitoring solutions, reinforcing long-term patient management capabilities.

Segment Covered in the Defibrillators Market:
By Product Type
The market is segmented into Implantable Cardioverter Defibrillators (ICDs) ~60% and External Defibrillators ~40%, with ICDs dominating due to their long-term use in high-risk cardiac patients and strong adoption in hospital and cardiac care settings. External defibrillators, including automated and semi-automated devices, continue to gain traction with rising public access programs, emergency preparedness initiatives, and increased awareness of sudden cardiac arrest.
By Age Group
Age groups include Adults ~85% and Pediatrics ~15%, with the adult segment leading due to the higher prevalence of cardiovascular diseases, arrhythmias, and sudden cardiac arrest among aging populations. Pediatric defibrillators show steady growth supported by advancements in child-specific device design and expanding emergency care infrastructure.
By End-User
End-users comprise Hospitals ~50%, Cardiac Centers ~25%, Homecare Settings ~15%, and Others ~10%, with hospitals and cardiac centers dominating due to the availability of advanced cardiac care facilities, trained healthcare professionals, and higher procedure volumes. Homecare settings witness growing adoption driven by technological advancements, remote monitoring capabilities, and a shift toward outpatient and home-based cardiac management.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=defibrillators-market?sindhuri
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Regional Analysis
North America - 38% Share
North America leads with ~38% share due to high SCA incidence, widespread AED placement in public venues, strong reimbursement policies, and advanced hospital infrastructure in the U.S. and Canada.
Europe - 28% Share
Europe holds ~28% share supported by aging population, increasing public-access AED programs, and strong regulatory frameworks in Germany, France, UK, Italy, and Spain.
Asia Pacific - 22% Share
Asia Pacific captures ~22% share driven by rapidly growing healthcare infrastructure, rising cardiovascular disease burden, government initiatives for public defibrillation, and increasing hospital spending in China, Japan, India, South Korea, and Australia.
Latin America - 7% Share
Latin America accounts for ~7% share with growth in private healthcare, urban emergency services, and gradual public-access adoption in Brazil, Mexico, and Argentina.
Middle East & Africa - 5% Share
Middle East & Africa holds ~5% share with increasing investments in hospital infrastructure, emergency response systems, and public safety programs in GCC countries and South Africa.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sindhuri
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.